| Date Filed | Type | Description |
| 06/16/2022 |
4
| Smith David V (Director) has filed a Form 4 on CODEXIS, INC.|
Txns:
| Gifted 4,796 shares
@ $0
Granted 11,273 shares
@ $0 |
|
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2022 |
4
| Smith David V (Director) has filed a Form 4 on IO Biotech, Inc.|
Txns:
| Granted 28,019 options to buy
@ $6.89, valued at
$193.1k
|
|
| 03/03/2022 |
3
| Smith David V (Director) has filed a Form 3 on IO Biotech, Inc. |
| 01/14/2022 |
5
| Smith David V (Director) has filed a Form 5 on CODEXIS, INC. |
| 06/17/2021 |
4
| Smith David V (Director) has filed a Form 4 on CODEXIS, INC.|
Txns:
| Gifted 8,952 shares
@ $0
Granted 4,796 shares
@ $0 |
|
| 04/19/2021 |
4
| Smith David V (Executive Vice President & CFO) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Granted 66,000 shares
@ $0
Disposed/sold 138,947 shares
@ $38, valued at
$5.3M
Disposed/sold 185,000 options to buy
@ $12.47, valued at
$2.3M
Disposed/sold 90,000 options to buy
@ $5.25, valued at
$472.5k
|
|
| 02/26/2021 |
4
| Smith David V (Executive Vice President & CFO) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 5,110 shares
@ $25.71, valued at
$131.4k
|
|
| 12/15/2020 |
4
| Smith David V (Executive Vice President & CFO) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 11,504 shares
@ $16.14, valued at
$185.7k
Exercised 22,000 options to buy
@ $0 |
|
| 11/30/2020 |
4
| Smith David V (Executive Vice President & CFO) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 6,920 shares
@ $18.45, valued at
$127.7k
|
|
| 11/13/2020 |
4
| Smith David V (Executive Vice President & CFO) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 10,908 shares
@ $18, valued at
$196.3k
Exercised 22,000 options to buy
@ $0 |
|
| 06/18/2020 |
4
| Smith David V (Director) has filed a Form 4 on CODEXIS, INC.|
Txns:
| Gifted 4,947 shares
@ $0
Granted 8,952 shares
@ $0 |
|
| 03/11/2020 |
4
| Smith David V (Executive Vice President & CFO) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Granted 15,000 shares
@ $0
Granted 90,000 options to buy
@ $5.25, valued at
$472.5k
|
|
| 11/27/2019 |
4
| Smith David V (Executive Vice President & CFO) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 6,611 shares
@ $3.77, valued at
$24.9k
|
|
| 06/26/2019 |
4
| Smith David V (Executive Vice President & CFO) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC|
Txns:
| Granted 44,000 options to buy
@ $0 |
|
| 06/13/2019 |
4
| Smith David V (Director) has filed a Form 4 on CODEXIS INC|
Txns:
| Granted 4,947 shares
@ $0 |
|
| 05/02/2019 |
3/A
| Smith David V (Executive Vice President & CFO) has filed a Form 3/A on FIVE PRIME THERAPEUTICS INC |
| 11/27/2018 |
4
| Smith David V (Executive Vice President & CFO) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC|
Txns:
| Granted 40,000 shares
@ $0
Granted 185,000 options to buy
@ $12.47, valued at
$2.3M
|
|
| 11/27/2018 |
3
| Smith David V (Executive Vice President & CFO) has filed a Form 3 on FIVE PRIME THERAPEUTICS INC |
| 06/12/2018 |
4
| Smith David V (Director) has filed a Form 4 on CODEXIS INC|
Txns:
| Granted 5,923 shares
@ $0 |
|
| 04/05/2018 |
4
| Smith David V (Director) has filed a Form 4 on CODEXIS INC|
Txns:
| Sold 6,000 shares
@ $10.3688, valued at
$62.2k
|
|
| 06/16/2017 |
4
| Smith David V (Director) has filed a Form 4 on CODEXIS INC|
Txns:
| Granted 17,894 shares
@ $0 |
|
| 06/17/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/27/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/24/2016 |
4
| Smith David V (Director) has filed a Form 4 on ONCOGENEX PHARMACEUTICALS, INC.|
Txns:
| Exercised 2,500 restricted stock units
@ $0 |
|
| 05/28/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/04/2012 |
4
| Smith David V (Director) has filed a Form 4 on ONCOGENEX PHARMACEUTICALS, INC.|
Txns:
| Granted 4,000 options to buy
@ $12.56, valued at
$50.2k
Granted 2,000 restricted stock units
@ $0 |
|
| 03/17/2011 |
4
| Smith David V (CFO & EVP) has filed a Form 4 on THORATEC CORP|
Txns:
| Paid exercise price by delivering 1,556 shares
@ $27.17, valued at
$42.3k
|
|
| 03/03/2011 |
4
| Smith David V (CFO & EVP) has filed a Form 4 on THORATEC CORP|
Txns:
| Granted 15,000 shares
@ $0
Paid exercise price by delivering 1,370 shares
@ $28.93, valued at
$39.6k
Granted 35,000 options to buy
@ $27.3, valued at
$955.5k
|
|
| 03/01/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/29/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/10/2010 |
4
| Smith David V (Director) has filed a Form 4 on ONCOGENEX PHARMACEUTICALS, INC.|
Txns:
| Granted 5,500 options to buy
@ $15.11, valued at
$83.1k
|
|
| 08/10/2010 |
3
| Smith David V (Director) has filed a Form 3 on ONCOGENEX PHARMACEUTICALS, INC. |
| 06/07/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|